Search
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 1 of 1 items.
XARELTO (rivaroxaban) - Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement
AlertHealth professional risk communication | 2018-12-20